Fresenius Medical Care (FMS) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Fresenius Medical Care reported robust growth in its operating income margin for Q3 2024, driven by organic revenue growth and improved U.S. dialysis treatment volumes. The company exceeded its FME25 savings target, achieving significant cost reductions, and further optimized its portfolio by divesting non-core assets. With a positive outlook, Fresenius continues to focus on enhancing operational performance and financial stability.
For further insights into FMS stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “They Read Like a Cry for Help”, Starbucks Stock (NASDAQ:SBUX) Notches Up Despite Cup Note Concerns
- “The Merger of Marketing and Tech has Never Been Greater”: Home Depot Stock (NYSE:HD) Swings Up With Growing Marketing Plans
- Why Arista Networks Stock (ANET) Is Down Today and Why Morgan Stanley Says ‘Take the Plunge’